Evogene (EVGN)
(Delayed Data from NSDQ)
$1.25 USD
-0.10 (-7.41%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.25 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Evogene Ltd. has a market cap of $6.71M, which represents its share price of $1.25 multiplied by its outstanding shares number of 5.37M. As a small-cap company, EVGN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
EVGN 1.25 -0.10(-7.41%)
Will EVGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EVGN based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for EVGN
Evogene Schedules Second Quarter 2025 Financial Results Release | EVGN Stock News
Evogene Updates Proxy Card for August 2025 Shareholder Meeting
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL | EVGN ...
EverGen Infrastructure Appoints Maria O’Sullivan as Interim CFO
Evogene Announces Annual General Meeting for August 2025